The market on Enzyme Linked Immunosorbent Assay (ELISA) is a relatively young and developing branch in diagnostics and life sciences companies industry due to the constantly escalating demand for precise qualitative diagnostic methods. ELISA is the most common immunoassay method for identifying and measuring antigens and antibodies in samples from the body With its uses in diagnosing diseases including the flu, HIV, hepatitis, and COVID-19, autoimmune diseases, as well as in determining the risk of developing cardiovascular diseases. The market is advancing due to high-throughput, technology automation, and multiplexing in ELISA technologies.

The Epilepsy Monitoring Devices Market relates the development and use of medical instruments enhanced for epilepsy diagnosis and treatment through observation of real-time signals from the brain. Patient compliance: These devices assist the clinicians in analysis of seizure pattern or inadequacy of treatments being offered and give comprehensive strategies for treating a patient with epilepsy. Such tools are video electroencephalography, intracranial electroencephalography, and other innovative monitoring tools for seizure control.